Herman received a B.S. in Environmental Science (2009) from the College of Santa Fe. She earned her Doctor of Pharmacy Degree (2015) from the University of New Mexico. She completed a two-year fellowship in cardiovascular pharmacotherapy at the University of New Mexico (2015-2017).

Personal Statement

Herman's primary clinical practice and research interest is women's health, with a focus on pharmacist provision of contraception and family planning services as a means to increase access to reproductive healthcare. She practices and precepts students in the inpatient OB/GYN services at the University of New Mexico Hospital. She is the co-medical director of the Reproductive Health tele ECHO program, a partnership with the NM Department of Health Family Planning Program, which disseminates best practices in women's health to participants across New Mexico. She serves as the coordinator of the pharmacy skills lab courses, which drives her interest in scholarship of teaching and learning, especially in simulation. She also has a long-standing passion for compounding, and serves as the COP delegate for the United States Pharmacopeia.

Areas of Specialty

Women's Health
Scholarship of Teaching & Learning


PharmD, University of New Mexico, 2015
BS, College of Santa Fe, 2009 (Environmental Science)

Achievements & Awards

UNM College of Pharmacy Faculty Appreciation Award, 2021
?UNM College of Pharmacy Faculty Preceptor of the Year, 2021
UNM College of Pharmacy Faculty Appreciation Award, 2019

Courses Taught

Herman provides ~150 hours of instruction in the COP curriculum each year, primarily in the pharmacy skills labs. She particularly enjoys teaching sterile compounding. She also created and teaches in the Topics in Women's Health elective.

Research and Scholarship

Winters A, Jakeman B, Gallegos Aragon K, Kasten Z, Bos A, Snyder J, Herman A. Contraceptive use and missed opportunities for family planning discussions in women living with human immunodeficiency virus receiving care at an outpatient primary care HIV clinic. Journal of the International Association of Providers of AIDS Care October 2022. DOI:

Thaxton L, Clark E, Wu JA, Herman A, Sussman AL, Espey E. Perspectives on pharmacy access to hormonal contraception among rural New Mexican women. Contraception: X. 2021;3(100069). DOI:

Rodriguez MI, Herman AM, Espey E, Hersh AR, Bachyrycz AM. Pharmacists’ perspectives and experience prescribing hormonal contraception in rural & urban New Mexico. Journal of the American Pharmacists Association. March-April 2021;61(2):e140-144. DOI:

Herman A, McCauley G, Thaxton L, Borrego M, Sussman A, Espey E. Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists. Journal of the American Pharmacists Association. 2020 April 2;S1544-3191(20). DOI:

Sible AM, Nawarskas JJ. Andexanet alfa for reversing factor Xa inhibition. Cardiol Rev. 2019 Mar/Apr;27(2):108-111.

Sible AM, Nawarskas JJ. Cangrelor: A new route for P2Y12 inhibition. Cardiol Rev. 2017 May/Jun;25(3):133-139.

Sible AM, Nawarskas JJ, Anderson JR. PCSK9 inhibitors: an innovative approach to treating hyperlipidemia. Cardiol Rev. 2016 May-Jun;24(3):141-52.

Sible AM, Nawarskas JJ, Alajajian D, Anderson JR. Sacubitril/valsartan: a novel cardiovascular combination agent. Cardiol Rev. 2016 Jan-Feb;24(1):41-47.